U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C16H15N4O2S.K
Molecular Weight 366.479
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of SULFAPYRAZOLE POTASSIUM

SMILES

[K+].CC1=NN(C([N-]S(=O)(=O)C2=CC=C(N)C=C2)=C1)C3=CC=CC=C3

InChI

InChIKey=MWUREILIWHVJSJ-UHFFFAOYSA-N
InChI=1S/C16H15N4O2S.K/c1-12-11-16(20(18-12)14-5-3-2-4-6-14)19-23(21,22)15-9-7-13(17)8-10-15;/h2-11H,17H2,1H3;/q-1;+1

HIDE SMILES / InChI

Description

Sulfazamet is a sulfanilamide derivative that exhibits antibacterial activity against Streptococci sepsis

Originator

Frisk, A. Rune
3
Sources: Acta Medica Scandinavica, Supplementum (1943), 142, 1-199.

Approval Year

Unknown
149124
Patents

Patents

GB848627
3
Name Type Language
SULFAPYRAZOLE POTASSIUM
Common Name English
BENZENESULFONAMIDE, 4-AMINO-N-(3-METHYL-1-PHENYL-1H-PYRAZOL-5-YL)-, POTASSIUM SALT (1:1)
Preferred Name English
SULFANILAMIDE, N1-(3-METHYL-1-PHENYLPYRAZOL-5-YL)-, MONOPOTASSIUM SALT
Common Name English
Code System Code Type Description
PUBCHEM
71587022
Created by admin on Mon Mar 31 21:42:03 GMT 2025 , Edited by admin on Mon Mar 31 21:42:03 GMT 2025
PRIMARY
FDA UNII
NR381B8DF1
Created by admin on Mon Mar 31 21:42:03 GMT 2025 , Edited by admin on Mon Mar 31 21:42:03 GMT 2025
PRIMARY
EPA CompTox
DTXSID00171188
Created by admin on Mon Mar 31 21:42:03 GMT 2025 , Edited by admin on Mon Mar 31 21:42:03 GMT 2025
PRIMARY
CAS
18179-68-5
Created by admin on Mon Mar 31 21:42:03 GMT 2025 , Edited by admin on Mon Mar 31 21:42:03 GMT 2025
PRIMARY
ACTIVE MOIETY
Structure of SULFAZAMET
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966